InsidersTradesSigma
Follow the National Health Investors INC share price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, National Health Investors INC has recorded 90 insider filings. Market capitalisation: €3.6bn. The latest transaction was filed on 17 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Spaid John L. The full history is accessible without an account.
90
Insider Decl.
n/a
Thresholds
€1m
14 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate National Health Investors INC Buy (bullish), based on 8 analysts. Average price target: US$82.75.
31Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,360 of 28,985 companies
62.0
score / 100
Value54
Quality70
FCF yld6.7%
Earn yld4.0%
EV/EBITDA17.1x
ROE11%
Gross mgn97%
Net mgn38%
Debt/EBITDA4.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 August 2026
Declarations90 total
33,124 shares@ US$72.50Common StockSEC144:0001949846-26-000519
2,370 shares0Common StockSEC:0000877860-26-000182:0
4,726 shares0Common StockSEC:0000877860-26-000088:0
5,072 shares0Common StockSEC:0000877860-26-000086:0
1,268 shares0Common StockSEC:0000877860-26-000084:0
1,268 shares0Common StockSEC:0000877860-26-000082:0
1,268 shares0Common StockSEC:0000877860-26-000080:0
1,268 shares0Common StockSEC:0000877860-26-000078:0
1,268 shares0Common StockSEC:0000877860-26-000076:0
1,268 shares0Shares Of Common StockSEC:0000877860-26-000074:0
5,072 shares0Common StockSEC:0000877860-26-000070:0
4,726 shares0Common StockSEC:0000877860-26-000072:0
14,409 shares0Common StockSEC:0000877860-26-000068:0
3,458 shares0Common StockSEC:0000877860-26-000066:0
2,420 shares0Common StockSEC:0000877860-26-000064:0
8,333 shares@ US$57.7619.9% of flowCommon StockSEC:0000877860-26-000043:0
8,500 shares@ US$57.7610.8% of flowCommon StockSEC:0000877860-26-000041:0
13,334 shares@ US$57.769.6% of flowCommon StockSEC:0000877860-26-000039:0
8,500 shares@ US$57.7614.3% of flowCommon StockSEC:0000877860-26-000037:0
10,000 shares@ US$73.3431.5% of flowCommon StockSEC:0000877860-26-000032:0
25,000 shares@ US$73.3422.9% of flowCommon StockSEC:0000877860-26-000026:0
10,000 shares@ US$73.3418.4% of flowCommon Stock - Jointly held with spouseSEC:0000877860-26-000024:0
10,000 shares@ US$73.3418.2% of flowShares Of Common StockSEC:0000877860-26-000022:0
15,000 shares@ US$73.3424.0% of flowCommon StockSEC:0000877860-26-000020:0
2,404 shares@ US$53.415.3% of flowCommon StockSEC:0000877860-26-000018:0
25 of 90 declarations
About National Health Investors INC
National Health Investors, Inc. (NYSE:NHI) is a U.S.-based healthcare real estate investment trust focused on senior housing and medical real estate. The company was established in 1991 as a Maryland corporation and operates as a self-managed REIT. Its corporate headquarters and operating base are in Murfreesboro, Tennessee, and its property and lending exposure is concentrated entirely in the United States. NHI’s business model is organized around two reportable segments. The Real Estate Investments segment includes real estate ownership, leases, and mortgage and other notes receivable tied to independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, and hospitals. The SHOP segment, or Senior Housing Operating Portfolio, consists of ventures that own and operate independent living and assisted living assets through third-party managers. This structure gives NHI a hybrid profile: part of the portfolio generates contractual triple-net rental income, while the SHOP assets provide more direct exposure to operating performance in senior housing. From a competitive standpoint, NHI is positioned as a specialized healthcare REIT with a long operating history and a diversified multi-state footprint. Its strategy is centered on need-driven and discretionary senior housing as well as select medical facilities, which allows it to serve an aging demographic while balancing asset-level risk. The company funds investments through operating cash flow, debt capital, and equity issuance. As of year-end 2024, NHI reported gross investments of approximately $2.6 billion across 172 healthcare real estate properties in 31 states, primarily leased under triple-net arrangements to 27 tenants, plus a portfolio of 16 mortgages and other notes receivable. Its SHOP platform comprised 15 properties across eight states. Recent developments indicate an active capital-recycling and growth strategy. In 2025, NHI reported solid operating results and provided 2026 guidance for FFO and FAD that pointed to continued improvement, while keeping leverage within its targeted range. In the first quarter of 2026, the company announced additional portfolio activity, including the acquisition of a nine-property assisted living portfolio for $105.5 million, and disclosed a sizeable investment pipeline that is primarily focused on SHOP assets and senior housing sale-leaseback opportunities. That suggests management is prioritizing private-pay senior housing, disciplined underwriting, and selective expansion. For French, Belgian, and Swiss investors, NHI is a U.S. NYSE-listed healthcare real estate name with a defensive income profile, but one that remains sensitive to interest rates, operator credit quality, lease renewals, and execution risk across senior housing transitions and acquisitions.
